Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension.

Delbosc S, Haloui M, Louedec L, Dupuis M, Cubizolles M, Podust VN, Fung ET, Michel JB, Meilhac O.

Mol Med. 2008 Jul-Aug;14(7-8):383-94. doi: 10.2119/2008-00030.Delbosc.

PMID:
18496584
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil.

Küng CF, Moreau P, Takase H, Lüscher TF.

Hypertension. 1995 Nov;26(5):744-51.

PMID:
7591013
[PubMed - indexed for MEDLINE]
Free Article
3.

Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.

López RM, Ortíz CS, Ruíz A, Vélez JM, Castillo C, Castillo EF.

Fundam Clin Pharmacol. 2004 Dec;18(6):669-77.

PMID:
15548238
[PubMed - indexed for MEDLINE]
4.

Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency.

Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W, Prachaney P, Phisalaphong C.

Hypertens Res. 2012 Apr;35(4):418-25. doi: 10.1038/hr.2011.180. Epub 2011 Nov 10.

PMID:
22072109
[PubMed - indexed for MEDLINE]
5.

Endothelum-dependent and-independent relaxations in aortic rings obtained from hypertensive hooded (Aguti) rats.

Moyiminiyi FB, Anibogu CN, Sofola OA, Adigun SA.

Niger J Physiol Sci. 2007 Jun-Dec;22(1-2):109-16.

PMID:
18379629
[PubMed - indexed for MEDLINE]
6.

Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.

Kumai T, Oonuma S, Matsumoto N, Takeba Y, Taniguchi R, Kamio K, Miyazu O, Koitabashi Y, Sekine S, Tadokoro M, Kobayashi S.

Life Sci. 2004 Mar 12;74(17):2129-42.

PMID:
14969717
[PubMed - indexed for MEDLINE]
7.

In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester.

Henrion D, Dowell FJ, Levy BI, Michel JB.

Hypertension. 1996 Sep;28(3):361-6.

PMID:
8794817
[PubMed - indexed for MEDLINE]
Free Article
8.

Counter-regulation by atorvastatin of gene modulations induced by L-NAME hypertension is associated with vascular protection.

Nadaud S, Dupuis M, Brocheriou I, Haloui M, Louedec L, Capron F, Michel JB, Soubrier F.

Vascul Pharmacol. 2009 Oct;51(4):253-61. doi: 10.1016/j.vph.2009.06.011. Epub 2009 Jul 5.

PMID:
19586617
[PubMed - indexed for MEDLINE]
9.

Abundance of the Na-K-2Cl cotransporter NKCC2 is increased by high-fat feeding in Fischer 344 X Brown Norway (F1) rats.

Riazi S, Tiwari S, Sharma N, Rash A, Ecelbarger CM.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F762-70. doi: 10.1152/ajprenal.90484.2008. Epub 2009 Feb 4.

PMID:
19193725
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Endothelium-dependent relaxation in pulmonary arteries of L-NAME-treated Wistar and stroke-prone spontaneously hypertensive rats.

Sekiguchi F, Yamamoto K, Matsuda K, Kawata K, Negishi M, Shinomiya K, Shimamur K, Sunano S.

J Smooth Muscle Res. 2002 Oct;38(4-5):131-44.

PMID:
12596891
[PubMed - indexed for MEDLINE]
Free Article
11.

Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.

Priviero FB, Teixeira CE, Claudino MA, De Nucci G, Zanesco A, Antunes E.

Eur J Pharmacol. 2007 Oct 1;571(2-3):189-96. Epub 2007 Jun 13.

PMID:
17610863
[PubMed - indexed for MEDLINE]
12.

Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.

Simko F, Matúsková J, Lupták I, Pincíková T, Krajcírovicová K, Stvrtina S, Pomsár J, Pelouch V, Paulis L, Pechánová O.

Physiol Res. 2007;56 Suppl 2:S25-32. Epub 2007 Sep 5.

PMID:
17824810
[PubMed - indexed for MEDLINE]
Free Article
13.

Betulinic acid ameliorates endothelium-dependent relaxation in L-NAME-induced hypertensive rats by reducing oxidative stress.

Fu JY, Qian LB, Zhu LG, Liang HT, Tan YN, Lu HT, Lu JF, Wang HP, Xia Q.

Eur J Pharm Sci. 2011 Oct 9;44(3):385-91. doi: 10.1016/j.ejps.2011.08.025. Epub 2011 Sep 1.

PMID:
21907795
[PubMed - indexed for MEDLINE]
14.

P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1.

Nerurkar SS, Olzinski AR, Frazier KS, Mirabile RC, O'Brien SP, Jing J, Rajagopalan D, Yue TL, Willette RN.

Biomarkers. 2007 Jan-Feb;12(1):87-112.

PMID:
17438656
[PubMed - indexed for MEDLINE]
15.
16.

Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.

Bartunek J, Weinberg EO, Tajima M, Rohrbach S, Katz SE, Douglas PS, Lorell BH.

Circulation. 2000 Feb 1;101(4):423-9.

PMID:
10653835
[PubMed - indexed for MEDLINE]
Free Article
17.

Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat.

Ochodnický P, Henning RH, Buikema HJ, de Zeeuw D, Provoost AP, van Dokkum RP.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F625-33. doi: 10.1152/ajprenal.00289.2009. Epub 2009 Dec 9.

PMID:
20007352
[PubMed - indexed for MEDLINE]
Free Article
18.

[Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?].

Moreau P, Takase H, Küng CF, Lüscher TF.

Arch Mal Coeur Vaiss. 1995 Aug;88(8):1141-3. French.

PMID:
8572861
[PubMed - indexed for MEDLINE]
19.

Blood pressure and the susceptibility to renal damage after unilateral nephrectomy and L-NAME-induced hypertension in rats.

van Dokkum RP, Jacob HJ, Provoost AP.

Nephrol Dial Transplant. 2000 Sep;15(9):1337-43.

PMID:
10978388
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk